Matinas BioPharma (MTNB) Cash flow

1,537 Followers

Matinas BioPharma Cash Flow

MTNB's free cash flow for Q4 2025 was $-1.51M. For the 2025 fiscal year, MTNB's free cash flow was decreased by $8.87M and operating cash flow was $-1.51M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -7.01M	$ -15.88M	$ -15.28M	$ -19.16M	$ -15.22M
Investing Cash Flow	$ 335.00K	$ 9.21M	$ 13.24M	$ 4.88M	$ 16.77M
Financing Cash Flow	$ 3.39M	$ 9.17M	$ -7.00K	$ 79.00K	$ 6.96M
End Cash Position	$ 4.25M	$ 7.53M	$ 5.04M	$ 6.88M	$ 21.28M
Free Cash Flow	$ -7.01M	$ -15.88M	$ -15.50M	$ -20.05M	$ -15.48M

Currency in USD